Skip to main content

Not investment advice.Read full disclaimer

BDRX: Biodexa Pharmaceuticals Plc Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.02×avg

Market Cap

520047USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Continue with finqOS

Explore Biodexa Pharmaceuticals Plc's financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Biodexa Pharmaceuticals Plc

BDRXNASDAQ Capital Market·USD·Closed

Biodexa Pharmaceuticals Plc

BDRXNASDAQ·USD·Closed

$3.10

−4.91%

$3.10

−$0.16 (4.91%)

52W Range

0thpctl

Volume

0.02×avg

Mkt Cap

520047USD

P/E

-0.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings